Alfons A den Broeder (A den Broeder, A A den Broeder)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Disease Activity

Systematic Review

Atopic Dermatitis

Top Venues

Scandinavian journal of rheumatology

The Journal of rheumatology

Rheumatology international

Health psychology review

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Schapink, Nathan den Broeder, Alfons A den Broeder, Lise M Verhoef
Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study. Rheumatology international (2024)
Max M H Teuwen, Salima Francis Elisabeth van Weely, Thea P M Vliet Vlieland, Thom Douw, Dirkjan van Schaardenburg, Alfons A den Broeder, Astrid van Tubergen, Maria A T van Wissen, Cornelia H M van den Ende, Maaike Gerarda Johanna Gademan
Functional limitations of people with rheumatoid arthritis or axial spondyloarthritis and severe functional disability: a cross-sectional descriptive study. Rheumatology international (2023)
Maria A T van Wissen, B Straathof, Thea P M Vliet Vlieland, Cornelia H M van den Ende, Max M H Teuwen, Wilfred F Peter, Alfons A den Broeder, Wilbert B van den Hout, Dirkjan van Schaardenburg, Astrid van Tubergen, Maaike Gerarda Johanna Gademan, Salima Francis Elisabeth van Weely
Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning. Scandinavian journal of rheumatology (2023)
Selma Atalay, Sophie E Berends, Hans M M Groenewoud, Ron A A Mathot, Marcellus D Njoo, Johannes M Mommers, Paul M Ossenkoppele, Marjolein I A Koetsier, Maartje A M Berends, Annick de Vries, Peter Cornelis Maria van de Kerkhof, Alfons A den Broeder, Elke M G J de Jong, Juul M P A van den Reek
Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial. The Journal of dermatological treatment 33 (5) (2022)
S C Heslinga, Charlotte E Teunissen, Rabia Agca, Diane van der Woude, Thomas Wj Huizinga, Jacob M van Laar, Alfons A den Broeder, Willem F Lems, Michael T Nurmohamed
NT-proBNP and sRAGE levels in early rheumatoid arthritis. Scandinavian journal of rheumatology (2022)
Thomas E Bolhuis, Lizanne E A Nizet, Claire Elizabeth Owen, Alfons A den Broeder, Cornelia H M van den Ende, Aatke van der Maas
Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review. The Journal of rheumatology 49 (6) (2022)
Chiara Gasteiger, Alfons A den Broeder, Sarah Stewart, Norina Gasteiger, Urte Scholz, Nicola Dalbeth, Keith J Petrie
The mode of delivery and content of communication strategies used in mandatory and non-mandatory biosimilar transitions: a systematic review with meta-analysis. Health psychology review (2021)
Daphne C Rohrich, Eline H M van de Wetering, Alexander J Rennings, Elke E Arts, Inger L Meek, Alfons A den Broeder, Jaap Fransen, Calin D Popa
Younger age and female gender are determinants of underestimated cardiovascular risk in rheumatoid arthritis patients: a prospective cohort study. Arthritis research & therapy 23 (1) (2021)
Maria A T van Wissen, Max M H Teuwen, Cornelia H M van den Ende, Thea P M Vliet Vlieland, Alfons A den Broeder, Wilbert B van den Hout, Wilfred F Peter, Dirkjan van Schaardenburg, Astrid van Tubergen, Maaike Gerarda Johanna Gademan, Salima Francis Elisabeth van Weely
Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials. Physiotherapy research international : the journal for researchers and clinicians in physical therapy (2021)
Wietske Kievit, Alfons A den Broeder
If You Want to Perform a Cost-effectiveness Trial, First Do a Modeling Study. The Journal of rheumatology 48 (4) (2021)